Potassium for Potassium Deficiency

Potassium chloride is how doctors treat low blood potassium (hypokalemia, below 3.5 mmol/L), and it does raise the number. In an open randomized trial that split 42 hypokalemic patients between potassium chloride and potassium citrate/bicarbonate, 80 mmol of potassium a day as potassium chloride lifted serum potassium from 3.2 to 3.8 mmol/L by day 2 and 4.0 mmol/L by day 4 (Meyer-Lehnert 1991). In a double-blind crossover trial of 16 hypertensive patients with diuretic-induced hypokalemia, 60 mmol a day for six weeks raised it by an average of 0.56 mmol/L (Kaplan 1985).

Moderate doses did not always get there. In nine patients taking a thiazide diuretic, 7 stayed hypokalaemic on 64 mmol of potassium chloride a day (Jackson 1982). In 16 hypokalemic patients, 24 to 96 mEq a day normalized potassium in only 8 (Papademetriou 1985), and in 19 patients 60 to 80 mmol a day failed to prevent hypokalemia in 7 (Maronde 1986). These trials are small, mostly from the 1980s, and measured blood levels rather than heart events. For the condition itself, causes and symptoms, see our potassium deficiency page; for the mineral, see potassium.

If low potassium has not responded to treatment, magnesium may be the missing piece. Our guide on magnesium and potassium together explains the link.

Potassium lives mostly inside cells. Only about 2% of the body's potassium is in the fluid outside them, so a small fall in blood potassium can mean a large fall in the body's stores, and a review of the topic concludes that repletion needs substantial and prolonged supplementation (Weir 2015). A review of therapy adds that, when nothing else is shifting potassium into cells, the blood level is a rough index of total stores (Kim 2002).

Oral potassium chloride is taken up in the small intestine, so the dose you swallow does enter the pool; the prescribing label notes the potassium chloride in its extended-release tablets is completely absorbed before it leaves the small intestine.

Replacement refills the pool but does not stop the leak. Hospital surveys point to diarrhea and vomiting, diuretics and poor intake as the usual causes, often more than one at once: in 61 patients below 2.5 mmol/L in a Scottish hospital, diarrhoea and/or vomiting accounted for 51% and diuretics for 47% (Reid 2012). If the cause continues, so does the deficit.

Low magnesium is a common, easily unrecognised reason that replacement fails. Magnesium deficiency makes the kidneys secrete more potassium and renders hypokalemia refractory to potassium treatment (Huang 2007), and a review found a magnesium deficit in 38% to 42% of potassium-depleted patients, advising that serum magnesium be checked routinely (Whang 1992). The NIH fact sheet notes more than half of people with clinically significant hypokalemia might be magnesium deficient. Whether fixing the blood number also fixes what hypokalemia does to the heart is a separate question, covered under the evidence below. Our magnesium and magnesium deficiency pages cover the other side.

Trials used 20 to 96 mmol of potassium a day for days to months. The label for potassium chloride extended-release tablets says the typical range for treating hypokalemia is 40 to 100 mEq a day, divided so that no more than 40 mEq is taken at once, and about 20 mEq a day for prevention. It also says to monitor serum potassium and adjust the dose, to take tablets with meals and a full glass of liquid, and to swallow them whole.

Potassium is monovalent, so 1 mEq equals 1 mmol. A 10 mEq tablet holds about 390 mg of potassium, while the NIH Office of Dietary Supplements reports that most potassium-only supplements contain up to 99 mg, because the FDA has ruled that some oral potassium chloride drug products above that amount are unsafe due to small-bowel lesions. A 99 mg supplement is roughly one-quarter of a single 10 mEq tablet.

Several trials show a clear rise. Beyond Meyer-Lehnert and Kaplan above, a trial of 447 hypertensive patients, 252 of whom developed hypokalemia on hydrochlorothiazide 50 mg a day, found that 40 mmol of potassium daily restored serum potassium better than 20 mmol; levels rose within a week and then held (Schnaper 1989). In the Kaplan crossover, blood pressure also fell by an average of 5.5 mm Hg alongside the potassium rise (P = 0.004).

Three trials show the limits. Jackson and colleagues concluded that potassium chloride does not correct moderate diuretic-induced hypokalaemia even at 64 mmol a day, while spironolactone and triamterene produced significant dose-related rises in plasma potassium. In 23 patients with heart failure on hydrochlorothiazide 50 mg twice a day, potassium chloride 1 g twice a day was less effective than amiloride or triamterene at holding potassium and magnesium over five months, though raising the dose corrected the level (Kohvakka 1988). A 10-patient crossover found 2 g potassium chloride a day (27 mmol) did not efficiently correct potassium, while potassium plus magnesium raised both in the first two weeks, with a fading effect by six (Kohvakka 1989).

Potassium-sparing drugs raised potassium as well as or better than potassium chloride in several trials, but they raise the risk of hyperkalemia and are a prescriber's choice; they should never be combined with potassium chloride on your own. Among salts, potassium-magnesium citrate matched potassium chloride in 60 healthy volunteers given hydrochlorothiazide 50 mg (both rose from about 3.4 to 3.8 mEq/L), and also raised serum magnesium by 0.11 to 0.12 mEq/L (Wuermser 2000).

Clinical reviews advise oral potassium chloride when the gut works and potassium is above 2.5 mEq/L, with intravenous treatment for severe or symptomatic cases (Kim 2023; Beekhuizen 2026). The supporting trials are modest. A cross-sectional analysis of protocol doses in 142 intensive-care patients (278 doses) found 20 mmol raised potassium by 0.25 mmol/L intravenously and 0.27 mmol/L enterally (DeCarolis 2016). In 41 children after cardiac surgery, allocated by alternating weeks, enteral and intravenous replacement raised potassium by 0.86 and 0.82 mmol/L, a difference that was not statistically significant (Rehman Siddiqu 2017). In older people with heart failure and moderate to severe hypokalaemia, enteral supplementation was equivalent in efficacy, but T-wave normalisation came sooner with high-concentration intravenous potassium, which the authors say may recover potassium faster (Zheng 2021).

Raising a blood number is a surrogate outcome. In 16 patients monitored for 24 hours before and after correction (potassium 2.83 to 3.73 mEq/L), ventricular ectopic beats improved in 5, worsened in 10 and were unchanged in 1 (Papademetriou 1983); this was uncontrolled. The 233-man trial found hydrochlorothiazide lowered potassium by 0.4 mmol/L and supplements did not shift that average, but all 12 men who fell to 3.0 mmol/L or below were in the unsupplemented group, and ventricular arrhythmias were twice as common among those 12 (Siegel 1992).

Outcome data are thin. In 167 peritoneal dialysis patients with hypokalemia, protocol-based replacement to 4 to 5 mEq/L cut peritonitis (HR 0.47, 95% CI 0.24 to 0.93) but not mortality or hospitalization, in an open-label design (Pichitporn 2022). In a review of 26,471 hospital admissions, patients with hypokalaemia (about 22%) stayed longer (11.2 vs 6.6 days) and died more often (5.1% vs 3.1%) than those with normal potassium (Greco 2016); that is an association, and the abstract cannot separate low potassium from the illness behind it. A cardiology working group proposes raising low-normal potassium in people with heart disease, and calls its proposals interim until more evidence is available (Krogager 2021).

Nausea, vomiting, flatulence, abdominal pain and diarrhea are the most common effects of oral potassium salts. Solid tablets can cause ulcerative or stenotic lesions in the gut, particularly if they linger on the lining, which is why the label says to take them with meals, to swallow them whole, and to stop and seek help for severe vomiting, abdominal pain or bleeding. People with swallowing problems may be given liquid.

The larger danger is too much. In healthy people with normal kidney function, oral potassium salts rarely cause serious hyperkalemia, but if excretion is impaired it can be fatal, and it is often silent until the heart is affected. The NIH fact sheet notes that in people with chronic kidney disease or on ACE inhibitors or potassium-sparing diuretics, even intakes below the adequate intake can cause hyperkalemia, and that hyperkalemia can also occur with type 1 diabetes, heart failure, adrenal insufficiency or liver disease. For kidney disease and cirrhosis, the label says to start at the low end of the dosing range and monitor potassium often. In a meta-analysis of 20 randomized trials (1,216 relatively healthy people, 22 to 140 mmol a day), supplements raised blood potassium by only 0.14 mmol/L and left creatinine unchanged (Cappuccio 2016), which does not apply to kidney disease or hypokalemia.

For pregnancy, the label states there are no human data, and supplementation that does not lead to hyperkalemia is not expected to cause fetal harm. Milk potassium is about 13 mEq/L, so replacement should have little or no effect while body potassium is not excessive. The label also says safety and effectiveness in children have not been established, and in older adults to start at the low end of the dose range.

Interactions run both ways. Loop and thiazide diuretics increase urinary potassium loss and can cause hypokalemia, and experts advise monitoring potassium and starting supplementation if warranted (NIH Office of Dietary Supplements). Drugs that reduce potassium excretion can push it too high. Our guide to blood pressure medications and supplements explains how common blood pressure drugs push potassium up or down.